InsiderSignal.AI

InsiderSignal.ai

TARS - Tarsus Pharmaceuticals, Inc.

Insider Sale by Link William J Phd (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Link William J Phd, serving as Dir at Tarsus Pharmaceuticals, Inc. (TARS), sold 12,500 shares at $68.79 per share, for a total transaction value of $859,819.00. Following this transaction, Link William J Phd now holds 116,332 shares of TARS.

This sale represents a 10.00% decrease in Link William J Phd's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 2 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Link William J Phd

Dir

William J. Link, PhD is a prominent venture capitalist and healthcare executive specializing in early-stage biopharma and medical device investments. He is the Founder and Managing Partner of Flying L Partners and a Founder and Managing Director of Versant Ventures. Previously, he served as a general partner at Brentwood Venture Capital, Founder, Chairman, and CEO of Chiron Vision (sold to Bausch & Lomb in 1997), and Founder and President of American Medical Optics (sold to Allergan in 1986). Before entering industry, he was an assistant professor in the Department of Surgery at Indiana University School of Medicine.[[1]](https://www.gurufocus.com/insider/17758/link-william-j-phd)[[2]](https://eyexora.com/team/william-j-link/)[[3]](https://tarsusrx.com/our-leadership/) Dr. Link holds BS, MS, and PhD degrees in Mechanical Engineering from Purdue University. He currently serves as a Director at Tarsus Pharmaceuticals, Inc. (TARS), where he recently engaged in insider transactions, including an acquisition on August 12, 2024, and owns approximately 177,544 shares valued at over $8 million. His board experience includes Glaukos Corp (GKOS), LENSAR Inc (LNSR), Oyster Point Pharma Inc (OYST), RxSight, and Edwards Lifesciences Corp (EW).[[1]](https://www.gurufocus.com/insider/17758/link-william-j-phd)[[2]](https://eyexora.com/team/william-j-link/)[[3]](https://tarsusrx.com/our-leadership/)[[4]](https://www.nasdaq.com/market-activity/insiders/link-william-j-phd-636473)

View full insider profile →

Trade Price

$68.79

Quantity

12,500

Total Value

$859,819.00

Shares Owned

116,332

Trade Date

Monday, March 16, 2026

7 days ago

SEC Filing Date

Wednesday, March 18, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Tarsus Pharmaceuticals, Inc.

Company Overview

No company information available
View news mentioning TARS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4896060

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime